Anti-PCSK9 VHH (P2.57) (TAB-0085CL-VHH)
This single domain antibody binding to PCSK9 is capable of lowering low-density lipoprotein-cholesterol (LDL-C) levels. It can be potentially used for the treatment of cardiovascular disorders.
- Recombinant PCSK9 protein
- Phage display library
- Single domain antibody
- Related Disease
- Cardiovascular disorders
- Alternative Names
- PCSK9; proprotein convertase subtilisin/kexin type 9; FH3; PC9; NARC1; LDLCQ1; NARC-1; HCHOLA3
- Entrez Gene ID
- UniProt ID
For lab research use only, not for diagnostic, therapeutic or any in vivo human use.
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us